Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Clinical Pharmacology and Therapeutics|March 7, 2013
A health-care system perspective on implementing genomic medicine: pediatric acute lymphoblastic leukemia as a paradigmW E Evans, K R Crews, C-H Pui
Clinical Pharmacology and Therapeutics|September 6, 2012
Pharmacogenomics and individualized medicine: translating science into practiceK R Crews, J K Hicks, C-H Pui, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2007
Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancerH Inaba, R B Khan, F H Laningham, et al.
British Journal of Clinical Pharmacology|April 25, 2001
Lack of effect of ondansetron on the pharmacokinetics and analgesic effects of morphine and metabolites after single-dose morphine administration in healthy volunteersK R Crews, B P Murthy, E K Hussey, et al.
Clinical Pediatrics|August 1, 1992
Outpatient management vs in-hospital management of children with new-onset diabetesH P Chase, K R Crews, S Garg, et al.
Clinical Pharmacology and Therapeutics|December 30, 2011
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotypeK R Crews, A Gaedigk, H M Dunnenberger, et al.
Clinical Pharmacology and Therapeutics|August 8, 2008
Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemiaG Stocco, M H Cheok, K R Crews, et al.
Leukemia|November 13, 2010
A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivityS-H Chen, W Yang, Y Fan, et al.
Clinical Pharmacology and Therapeutics|September 13, 2016
An Inherited Genetic Variant in CEP72 Promoter Predisposes to Vincristine-Induced Peripheral Neuropathy in Adults With Acute Lymphoblastic LeukemiaW Stock, B Diouf, K R Crews, et al.
Leukemia|February 27, 2009
Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trialJ E Rubnitz, K R Crews, S Pounds, et al.
Pageof 2